JNJ-404118413
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JNJ-404118413, covering 2013-09-26 to 2013-09-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of JNJ-404118413 in Healthy Male Patients [Phase 1]